Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
J Eric
JE
Ahlskog
Demetrius M
DM
Maraganore
Ryan J
RJ
Uitti
George R
GR
Uhl
D000978:Antiparkinson Agents / Q000494:pharmacology*; D052160:Benzothiazoles; D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects; D003042:Cocaine / Q000031:analogs & derivatives; D018491:Dopamine Agonists / Q000494:pharmacology*; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010300:Parkinson Disease / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000077487:Pramipexole; D019275:Radiopharmaceuticals; D013844:Thiazoles / Q000494:pharmacology*; D015899:Tomography, Emission-Computed, Single-Photon
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D019275:Radiopharmaceuticals; D013844:Thiazoles; C069723:2beta-carbomethoxy-3beta-(4-iodophenyl)tropane; D000077487:Pramipexole; D003042:Cocaine